Loading clinical trials...
Loading clinical trials...
Evaluation of the Hypoallergenicity of a New Thickened Extensively Hydrolyzed Formula in Infants With Confirmed Cow's Milk Protein Allergy
The aim of this study is to assess the hypoallergenicity of a new thickened extensively hydrolyzed formula, in infants with confirmed cow's milk protein allergy assessed through a double blind placebo controlled food challenge, followed by a 3-month open feeding period.
Age
0 - 3 years
Sex
ALL
Healthy Volunteers
No
Umberto I university hospital
Roma, Italy
Start Date
April 1, 2016
Primary Completion Date
August 31, 2017
Completion Date
November 29, 2017
Last Updated
May 15, 2018
30
ACTUAL participants
Extensively Hydrolyzed formula
DIETARY_SUPPLEMENT
Amino acid formula
DIETARY_SUPPLEMENT
Lead Sponsor
United Pharmaceuticals
NCT05785299
NCT04249973
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT04184700